⌘K

Home/Filings/4/0001824293-25-000035

4//SEC Filing

Kelly Leanne 4

Accession 0001824293-25-000035

CIK 0001824293other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:58 PM ET

Size

5.5 KB

Accession

0001824293-25-000035

Insider Transaction Report

Form 4

Period: 2025-01-23

GRI Bio, Inc.GRI

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2025-01-23$0.69/sh+43,319$29,704→ 43,319 total
Exercise: $0.69From: 2025-01-23Exp: 2035-01-23→ Common Stock (43,319 underlying)

Documents

1 file

4
wk-form4_1737759502.xmlPrimary
FORM 4

Issuer

GRI Bio, Inc.

CIK 0001824293

Entity typeother

Related Parties

1

filerCIK 0001398278

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 5:58 PM ET
Size: 5.5 KB

View on SEC.gov